BIOMAT Database Logo BIOMAT Database Logo

[Experimental and clinical studies of sulbactam/cefoperazone in pediatric field]. 1984

T Nakashima, and S Ueda, and F Hayakawa, and Y Miyachi, and S Hakamada, and K Kuno

Clinical trials were carried out with sulbactam/cefoperazone (SBT/CPZ) (combination ratio of 1:1) in pediatric infections. Results were as follows. The mean half-lives of SBT and CPZ in the serum following intravenous injection of SBT/CPZ were about 0.7 and 1.2 hours, respectively. Urinary excretions of SBT and CPZ within 6 hours after intravenous injection of SBT/CPZ were 81.9% and 28.1%, respectively. SBT/CPZ was administered to 33 pediatric patients with various infection; 18 respiratory tract infections, 12 urinary tract infections and 3 Salmonella enterocolitis. The overall efficacy rate was 87.9%. In particular, 7 of 8 urinary tract infections caused by beta-lactamase producing organisms were improved after administration of SBT/CPZ. Diarrhea in 8 and soft stool in 3 of 33 patients occurred, and slight elevation of GOT/GPT was observed in 2 patients.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D010397 Penicillanic Acid A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed) Acid, Penicillanic
D002438 Cefoperazone Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It may be used to treat Pseudomonas infections. Cefobid,Cefoperazon,Cefoperazone Sodium,Cefoperazone Sodium Salt,Céfobis,T-1551,T1551,Salt, Cefoperazone Sodium,Sodium Salt, Cefoperazone,Sodium, Cefoperazone,T 1551
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females

Related Publications

T Nakashima, and S Ueda, and F Hayakawa, and Y Miyachi, and S Hakamada, and K Kuno
[Clinical studies on sulbactam/cefoperazone in pediatric field].
October 1984, The Japanese journal of antibiotics,
T Nakashima, and S Ueda, and F Hayakawa, and Y Miyachi, and S Hakamada, and K Kuno
[Clinical studies on sulbactam/cefoperazone in the pediatric field].
October 1984, The Japanese journal of antibiotics,
T Nakashima, and S Ueda, and F Hayakawa, and Y Miyachi, and S Hakamada, and K Kuno
[Basic and clinical studies of sulbactam/cefoperazone in pediatric field].
October 1984, The Japanese journal of antibiotics,
T Nakashima, and S Ueda, and F Hayakawa, and Y Miyachi, and S Hakamada, and K Kuno
[Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
October 1984, The Japanese journal of antibiotics,
T Nakashima, and S Ueda, and F Hayakawa, and Y Miyachi, and S Hakamada, and K Kuno
[Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
October 1984, The Japanese journal of antibiotics,
T Nakashima, and S Ueda, and F Hayakawa, and Y Miyachi, and S Hakamada, and K Kuno
[Laboratory and clinical studies of sulbactam/cefoperazone in the pediatric field].
October 1984, The Japanese journal of antibiotics,
T Nakashima, and S Ueda, and F Hayakawa, and Y Miyachi, and S Hakamada, and K Kuno
[Bacteriological, pharmacokinetic and clinical studies on sulbactam/cefoperazone in the pediatric field].
December 1984, The Japanese journal of antibiotics,
T Nakashima, and S Ueda, and F Hayakawa, and Y Miyachi, and S Hakamada, and K Kuno
[Clinical experience on sulbactam/cefoperazone in the pediatric field].
October 1984, The Japanese journal of antibiotics,
T Nakashima, and S Ueda, and F Hayakawa, and Y Miyachi, and S Hakamada, and K Kuno
[Clinical studies of sulbactam/cefoperazone therapy in pediatric bacterial infections].
October 1984, The Japanese journal of antibiotics,
T Nakashima, and S Ueda, and F Hayakawa, and Y Miyachi, and S Hakamada, and K Kuno
[Fundamental and clinical studies of sulbactam/cefoperazone in the field of pediatrics].
November 1984, The Japanese journal of antibiotics,
Copied contents to your clipboard!